OtherPublishAheadOfPrint
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
Chieh Lin, Emmanuel Itti, Corinne Haioun, Yolande Petegnief, Alain Luciani, Jehan Dupuis, Gaetano Paone, Jean-Noël Talbot, Alain Rahmouni and Michel Meignan
Journal of Nuclear Medicine September 2007, DOI: https://doi.org/10.2967/jnumed.107.042093
Chieh Lin
Emmanuel Itti
Corinne Haioun
Yolande Petegnief
Alain Luciani
Jehan Dupuis
Gaetano Paone
Jean-Noël Talbot
Alain Rahmouni
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
Chieh Lin, Emmanuel Itti, Corinne Haioun, Yolande Petegnief, Alain Luciani, Jehan Dupuis, Gaetano Paone, Jean-Noël Talbot, Alain Rahmouni, Michel Meignan
Journal of Nuclear Medicine Sep 2007, DOI: 10.2967/jnumed.107.042093
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
Chieh Lin, Emmanuel Itti, Corinne Haioun, Yolande Petegnief, Alain Luciani, Jehan Dupuis, Gaetano Paone, Jean-Noël Talbot, Alain Rahmouni, Michel Meignan
Journal of Nuclear Medicine Sep 2007, DOI: 10.2967/jnumed.107.042093
Jump to section
Related Articles
Cited By...
- Validation of the {Delta}SUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
- Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2--Technical)
- Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma
- Follicular Lymphoma Treated with First-Line Immunochemotherapy: A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study
- Interim PET in Diffuse Large B-Cell Lymphoma
- Statistical Considerations in the Evaluation of Continuous Biomarkers
- Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the {Delta}SUVmax Method
- Derivation and utility of an A{beta}-PET pathology accumulation index to estimate A{beta} load
- Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma
- Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment 18F-FDG PET in Diffuse Large B-Cell Lymphoma
- Validation of the Semiautomatic Quantification of 18F-Fluoride PET/CT Whole-Body Skeletal Tumor Burden
- Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of {Delta}SUVmax in the FDG-Avid Patients of the IMAJEM Study
- Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
- FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
- Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?
- Repeatability of SUV in Oncologic 18F-FDG PET
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- Response Assessment Criteria and Their Applications in Lymphoma: Part 2
- Response Assessment Criteria and Their Applications in Lymphoma: Part 1
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- Midtreatment 18F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center
- Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia
- Interim 18F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma Patients
- Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab
- Prognostic Value of Interim and Posttherapy 18F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell Lymphomas
- Imaging Follicular Lymphoma Using Positron Emission Tomography With [18F]Fluorodeoxyglucose: To What Purpose?
- Interim PET-CT in the management of diffuse large B-cell lymphoma
- Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value
- Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
- Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- Role of Functional Imaging in the Management of Lymphoma
- 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
- How I treat elderly patients with diffuse large B-cell lymphoma
- Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background
- Can the Interim Fluorodeoxyglucose-Positron Emission Tomography Standardized Uptake Value Be Used to Determine the Need for Residual Mass Biopsy After Dose-Dense Immunochemotherapy for Advanced Diffuse Large B-Cell Lymphoma?
- Reply to A. Huttmann et al
- Pitfalls of Interim Positron Emission Tomography Scanning in Diffuse Large B-Cell Lymphoma
- Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
- 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
- Expert Opinions on Positron Emission Tomography and Computed Tomography Imaging in Lymphoma
- Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
- Development and Application of a Real-Time On-Line Blinded Independent Central Review of Interim Pet Scans to Determine Treatment Allocation in Lymphoma Trials
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
- 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
- 18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy
- Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors
- 18F-FDG PET in Non-Hodgkin's Lymphoma: Qualitative or Quantitative?